Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Summit Therapeutics

Clinical trials sponsored by Summit Therapeutics, explained in plain language.

Summit Therapeutics SMMT NASDAQ

A biopharmaceutical company developing novel therapies for infectious diseases and cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 1

New hope for lung cancer patients whose first treatment stopped working

Disease control Ongoing

This study tests whether adding the experimental drug AK112 to standard chemotherapy can help people with a specific type of advanced lung cancer (non-squamous non-small cell lung cancer with an EGFR mutation) whose cancer has worsened after initial targeted therapy. About 420 pa…

Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC